Faron Pharmaceuticals Oy (FARN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Faron Pharmaceuticals Oy (FARN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011694
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company’s product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the treatment of acute respiratory distress syndrome (ARDS) an orphan lung disease. Faron’s drug platform traumakine prevents vascular leakage through the injured endothelium of several central organs. Its pipeline products concentrates on the therapeutic areas of acute organ traumas, cancer immunotherapy and vascular damage. The company also works in collaboration with academic institutions. Faron Pharma is headquartered in Turku, Finland.

Faron Pharmaceuticals Oy (FARN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Faron Pharmaceuticals Oy, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Faron Pharmaceuticals Oy, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Faron Pharmaceuticals Oy, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Faron Pharmaceuticals Oy, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Faron Pharmaceuticals Oy, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Faron Pharmaceuticals Oy, Medical Equipment, Deal Details 10
Equity Offering 10
Faron Pharma Raises USD11.9 Million in Private Placement of Shares 10
Faron Pharma Raises USD1.3 Million in Rights Offering of Shares 12
Faron Pharma to Raise USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 13
Faron Pharma Raises Funds in IPO 14
Faron Pharmaceuticals Oy – Key Competitors 15
Faron Pharmaceuticals Oy – Key Employees 16
Faron Pharmaceuticals Oy – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Sep 06, 2017: Faron Pharmaceuticals: Interim Results for the six months ended 30 June 2017 18
Sep 05, 2016: Faron Pharmaceuticals Announces Interim Results for the six months ended 30 June 2016 20
Mar 10, 2016: Faron Pharmaceuticals: Annual Results for the year ended 31 December 2015 21
Corporate Communications 22
Dec 01, 2017: Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer 22
May 03, 2016: Faron Strengthens Executive Team by Appointing New Medical Director 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Faron Pharmaceuticals Oy, Medical Equipment, Key Facts, 2016 2
Faron Pharmaceuticals Oy, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Faron Pharmaceuticals Oy, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Faron Pharmaceuticals Oy, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Faron Pharmaceuticals Oy, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Faron Pharmaceuticals Oy, Deals By Market, 2011 to YTD 2017 8
Faron Pharmaceuticals Oy, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Faron Pharma Raises USD11.9 Million in Private Placement of Shares 10
Faron Pharma Raises USD1.3 Million in Rights Offering of Shares 12
Faron Pharma to Raise USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 13
Faron Pharma Raises Funds in IPO 14
Faron Pharmaceuticals Oy, Key Competitors 15
Faron Pharmaceuticals Oy, Key Employees 16

★海外企業調査レポート[Faron Pharmaceuticals Oy (FARN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inergy, L.P.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Inergy, L.P. Mergers and Acquis …
  • Denator AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Denator AB Mergers and Acquisit …
  • Cabela’s Incorporated:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cabela's Incorporated Mergers a …
  • Canada Pension Plan Investment Board:戦略・SWOT・企業財務分析
    Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report Summary Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Capita plc:企業のM&A・提携・投資分析
    Capita plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Capita plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Public Service Enterprise Group Incorporated:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Public Service Enterprise Group …
  • Galapagos NV (GLPGA):企業概要、財務及び戦略的SWOT分析
    Summary Galapagos NV (Galapagos) is a biotechnology company. The company develops, discovers and manufactures medicines. Its products include GLPG0634, GLPG0187, GLPG0778/555 and GLPG0974. The company’s GLPG0187 is an integrin receptor antagonist developed to treat metastases, a severe complication …
  • Camfin S.p.A:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Camfin S.p.A Mergers and Acquis …
  • Alkali Metals Limited (ALKALI):企業財務及び戦略的SWOT分析
    Summary Alkali Metals Limited (AML) is a chemical manufacturer that provides ranging from alkali metal derivatives, amino pyridines, tetrazoles, cyclic compounds and fine chemicals. The company’s cyclic compounds and fine chemicals products include phenyl-a-(2-pyridyl) acetonitrile, and phenyl pyrid …
  • Mubadala Development Company PJSC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mubadala Development Company PJ …
  • Arvind Remedies Ltd. (ARVINDREM):企業の財務及び戦略的SWOT分析
    Summary Arvind Remedies Ltd. (ARL) is a pharmaceutical company that offers contract manufacturing services. The company offers products through two categories, such as allopathic products and ayurvedic products. Its allopathic product includes generic products, branded generic products and ethical p …
  • JiangXi ChangJiu Biochemical Industry Co., Ltd. (600228):企業の財務及び戦略的SWOT分析
    Summary JiangXi ChangJiu Biochemical Industry Co., Ltd. (ChangJiu Biochemical), formerly Jiangxi Changjiu Chemicals Co., Ltd is a chemical company that manufactures acrylamide crystals, pharm-chemicals, fine chemicals and coal. The company’s products include urea, biological method acrylamide crysta …
  • Bionovo, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bionovo, Inc. Mergers and Acqui …
  • Barclays PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Barclays PLC Mergers and Acquis …
  • Medigus Ltd. (MDGS):企業の財務及び戦略的SWOT分析
    Summary Medigus Ltd. (Medigus) is a medical device company that designs, develops and manufactures endoscopic procedures and devices. The company’s muse system enables endoscopists to treat gastroesophageal reflux disease by performing a fundoplication procedure through the mouth. It offers products …
  • NEXUS Biosystems, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NEXUS Biosystems, Inc. Mergers …
  • 3P Biopharmaceuticals SL-製薬・医療分野:企業M&A・提携分析
    Summary 3P Biopharmaceuticals SL (3P), a subsidiary of Infarco SA is a biotechnology company that offers biological and cell therapy products. The company offers biologic services such as cell-banks, process development, GMP manufacturing and analytical QC services. Its cell therapy services compris …
  • TCR (London) Ltd:企業概要およびSWOT分析
    Summary Canadean's "TCR (London) Ltd: Foodservice - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, k …
  • ImageONE Co., Ltd. (2667):企業の財務及び戦略的SWOT分析
    Summary ImageONE Co., Ltd. (ImageOne) is a medical technology that provides digital image information products and services. The company offers medical information and integration systems, medical image viewers, iPad/iPhone, server systems, image viewer systems, ultrasound systems, radiology reporti …
  • MerLion Pharmaceuticals Pte. Ltd:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' MerLion Pharmaceuticals Pte. Lt …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆